Supernus Pharmaceuticals, Inc. Contracts & Agreements

116 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Executive Retention Agreement
Retention Agreements
Supernus Pharmaceuticals, Inc.
2024
Form of Time-Based Incentive Stock Option Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2024
Form of Non-Statutory Time-Based Stock Option Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2024
Form of Restricted Stock Unit Award Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2024
Form of Performance Share Unit Award Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2024
Settlement Agreement, dated as of June 21, 2023, by and between Supernus Pharmaceuticals, Inc. with Apotex Inc. and Apotex Corp
Settlement Agreements
Supernus Pharmaceuticals, Inc.
2024
Settlement Agreement, dated as of December 31, 2022, by and between Supernus Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Settlement Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Exhibit 10.1 Credit Line Agreement between UBS Bank USA and Supernus Pharmaceuticals, Inc. dated as of February 8, 2023
Credit Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2023
Amendment to Deed of Lease, August 23, 2021, by and between Supernus Pharmaceuticals, Inc. and Key West MD Owner, LLC
Lease Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2021
Agreement and Plan of Merger, dated as of October 10, 2021, by and among Supernus Pharmaceuticals, Inc., Supernus Reef, Inc. and Adamas Pharmaceuticals, Inc
Merger Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Commercial Supply Agreement, dated May 12, 2021, by and between Supernus Pharmaceuticals, Inc. and Catalent Pharma Solutions, LLC
Supply Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
API Supply Agreement, dated July 13, 2021, by and between Supernus Pharmaceuticals, Inc. and Bachem Americas, Inc
Supply Agreements
Supernus Pharmaceuticals, Inc.
2021
Form of Time-Based Incentive Stock Option Agreement, under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Form of Non-Statutory Time-Based Stock Option Agreement, under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Form of Restricted Stock Unit Award Agreement, under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2021
Form of Performance Share Unit Award Agreement, under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2021
Exhibit 10.1+ Offer Letter to Timothy C. Dec
Supernus Pharmaceuticals, Inc.
2021
Asset Purchase and Contribution Agreement, dated as of December
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Guanfacine License Agreement, dated as of December 22, 2005, by and among the Registrant, Shire LLC and Shire plc, as amended
License Agreements
Supernus Pharmaceuticals, Inc.
2021
Exclusive License Agreement, dated as of June 6, 2006, by and between the Registrant and United Therapeutics Corporation
License Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
MD
2021
Purchase and Sale Agreement, dated as of June 9, 2006, by and between the Registrant and Rune HealthCare Limited
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Consulting Agreement, made as of November 18, 2020, by and between the Company
Consulting Agreements
Supernus Pharmaceuticals, Inc.
2020
Consulting Agreement, made as of December 31, 2020, by and between the Company
Consulting Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
MD
2020
Offer Letter to James P. Kelly
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2020
EXECUTIVE RETENTION AGREEMENT
Retention Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
MD
2020
Exhibit 10.1+ Form of Restricted Stock Unit Award Agreement for Non-Management Directors, issued under the Supernus Pharmaceuticals, Inc., 2012 Equity Incentive Plan, as amended,...
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Exhibit 10.2+ Form of Performance Share Unit Award Agreement, issued under the Amended and Restated Stock Incentive Plan, for grants made to Jack A. Khattar, as an Exhibit...
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2020
Press Release Dated September 25, 2019
Release Agreements
Supernus Pharmaceuticals, Inc.
2019
Press Release Dated August 26, 2019
Release Agreements
Supernus Pharmaceuticals, Inc.
2019
Press Release Dated July 23, 2019
Release Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2019
Lease Agreement Dated January 31, 2019
Lease Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
WA
2019
Agreement and Plan of Merger, dated September 12, 2018, by and between Supernus Pharmaceuticals, Inc., Supernus Merger Sub, Inc., Biscayne Neurotherapeutics, Inc. and Reich...
Merger Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
FL
2018
Third Amendment to Amended and Restated Employment Agreement, dated May 8, 2018, between Supernus Pharmaceuticals, Inc. and Jack Khattar
Employment Agreements
Supernus Pharmaceuticals, Inc.
2018
Form of Amendment to Executive Retention Agreement
Retention Agreements
Supernus Pharmaceuticals, Inc.
2018
Purchase Agreement, dated March 14, 2018, among Supernus Pharmaceuticals, Inc. and Jefferies LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC
Purchase Agreements
Supernus Pharmaceuticals, Inc.
2018
Indenture, dated as of March 19, 2018, between Supernus Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Base Convertible Bond Hedge Transaction, dated March 14, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
2018
Base Convertible Bond Hedge Transaction, dated March 14, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Convertible Bond Hedge Transaction, dated March 14, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Issuer Warrant Transaction, dated March 14, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
2018
Base Issuer Warrant Transaction, dated March 14, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
2018
Base Issuer Warrant Transaction, dated March 14, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
2018
Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
2018
Additional Issuer Warrant Transaction, dated March 15, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Additional Issuer Warrant Transaction, dated March 15, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
2018
Additional Issuer Warrant Transaction, dated March 15, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
2018
Lease Agreement Dated February 27, 2018
Lease Agreements
Supernus Pharmaceuticals, Inc.
2018
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
2017
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
2016
SECOND AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Supernus Pharmaceuticals, Inc.
2016
FOURTH AMENDMENT TO LEASE
Lease Agreements
Supernus Pharmaceuticals, Inc.
2014
FIRST AMENDMENT TO LEASE AGREEMENT
Lease Agreements
Supernus Pharmaceuticals, Inc.
2014
EXECUTIVE RETENTION AGREEMENT
Retention Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
MD
2014
EXECUTIVE RETENTION AGREEMENT
Retention Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
MD
2014
SUPERNUS PHARMACEUTICALS, INC. AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Supernus Pharmaceuticals, Inc.
2014
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2014
SECURITY AGREEMENT
Security Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2014
Supernus to Receive $30 Million in Non-Dilutive Royalty Deal
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2014
FIRST SUPPLEMENTAL INDENTURE
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
2013
LEASE AGREEMENT
Lease Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2013
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. COMMERCIAL SUPPLY AGREEMENT
Exchange Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2013
[] Shares Supernus Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Supernus Pharmaceuticals, Inc.
2012
OFFER LETTER TO EXECUTIVE OFFICER
Supernus Pharmaceuticals, Inc.
2012
COMPENSATORY ARRANGEMENTS WITH EXECUTIVE OFFICERS
Supernus Pharmaceuticals, Inc.
2012
COMPENSATORY ARRANGEMENTS WITH EXECUTIVE OFFICERS
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
AMENDMENT NO. 2 TO STOCKHOLDERS VOTING AGREEMENT
Voting Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
STOCK RESTRICTION AGREEMENT
Stock Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
AMENDMENT NO. 2 TO STOCK RESTRICTION AGREEMENT
Stock Agreements
Supernus Pharmaceuticals, Inc.
2012
Supernus Pharmaceuticals, Inc. [ ] Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreements
Supernus Pharmaceuticals, Inc.
2012
STOCKHOLDERS VOTING AGREEMENT
Voting Agreements
Supernus Pharmaceuticals, Inc.
2012
SUPERNUS PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2012
SUPERNUS PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN SUPERNUS PHARMACEUTICALS, INC. STRONGLY ENCOURAGES YOU TO SEEK THE ADVICE OF YOUR OWN LEGAL AND FINANCIAL ADVISORS WITH...
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2012
SUPERNUS PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN SUPERNUS PHARMACEUTICALS, INC. STRONGLY ENCOURAGES YOU TO SEEK THE ADVICE OF YOUR OWN LEGAL AND FINANCIAL ADVISORS WITH...
Bonus & Incentive Agreements
Supernus Pharmaceuticals, Inc.
2012
SUPERNUS PHARMACEUTICALS, INC. 2012 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Supernus Pharmaceuticals, Inc.
2012
AMENDMENT NO. 2 TO INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
ASSET PURCHASE AND CONTRIBUTION AGREEMENT dated as of December 22, 2005 among SUPERNUS PHARMACEUTICALS, INC., SHIRE LABORATORIES INC. and SHIRE PLC
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
GUANFACINE LICENSE AGREEMENT
License Agreements
Supernus Pharmaceuticals, Inc.
2012
EXCLUSIVE OPTION AND LICENSE AGREEMENT
License Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
PURCHASE AND SALE AGREEMENT
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
EXCLUSIVE LICENSE AGREEMENT
License Agreements
Supernus Pharmaceuticals, Inc.
2012
Supernus Pharmaceuticals, Inc. 1550 East Gude Drive, Rockville, MD 20850 USA Phone: (301) 838-2500 Fax: (301) 838-2501 www.supernuspharma.com
Supernus Pharmaceuticals, Inc.
2012
Supernus Pharmaceuticals, Inc. 1550 East Gude Drive, Rockville, MD 20850 USA Phone: (301) 838-2500 Fax: (301) 838-2501 www.supernuspharma.com
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Supernus Pharmaceuticals, Inc.
2012
CONSULTING AGREEMENT
Consulting Agreements
Supernus Pharmaceuticals, Inc.
2012
AMENDED AND RESTATED WARRANT TO PURCHASE STOCK
Warrant Agreements
Supernus Pharmaceuticals, Inc.
2012
SECURED PROMISSORY NOTE - 1 (Term B Loan)
Loan Agreements
Supernus Pharmaceuticals, Inc.
2012
SECURED PROMISSORY NOTE - 2 (Term B Loan)
Loan Agreements
Supernus Pharmaceuticals, Inc.
2012
SECURED PROMISSORY NOTE (Term B Loan)
Loan Agreements
Supernus Pharmaceuticals, Inc.
2012
WARRANT TO PURCHASE STOCK
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
UNIT PURCHASE AGREEMENT dated as of December 14, 2011 by and between SUPERNUS PHARMACEUTICALS, INC., and ROYALTY OPPORTUNITIES S.r.I
Purchase Agreements
Supernus Pharmaceuticals, Inc.
2012
FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreements
Supernus Pharmaceuticals, Inc.
2012
SECURED PROMISSORY NOTE
Note Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2011
SECURED PROMISSORY NOTE
Note Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2011
WARRANT TO PURCHASE STOCK
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
ASSET PURCHASE AND CONTRIBUTION AGREEMENT dated as of December 22, 2005 among SUPERNUS PHARMACEUTICALS, INC., SHIRE LABORATORIES INC. and SHIRE PLC
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
GUANFACINE LICENSE AGREEMENT
License Agreements
Supernus Pharmaceuticals, Inc.
2011
EXCLUSIVE OPTION AND LICENSE AGREEMENT
License Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
PURCHASE AND SALE AGREEMENT
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
EXCLUSIVE LICENSE AGREEMENT
License Agreements
Supernus Pharmaceuticals, Inc.
2011
INDENTURE dated as of April 15, 2008 by and between TCD ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL...
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
LOAN AND SECURITY AGREEMENT
Loan Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2011
SUPERNUS PHARMACEUTICALS, INC. 2005 STOCK PLAN, AS OF DECEMBER 22, 2005 (PURSUANT TO BOARD RESOLUTION AND SHAREHOLDER CONSENT AS OF DECEMBER 21, 2005)
Stock Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2010
Confidential SUPERNUS PHARMACEUTICALS, INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN
Retirement Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
KY
2010
EMPLOYMENT AGREEMENT
Employment Agreements
Supernus Pharmaceuticals, Inc.
2010
SUPERNUS PHARMACEUTICALS, INC. STOCK RESTRICTION AGREEMENT
Stock Agreements
Supernus Pharmaceuticals, Inc.
2010
Shire Laboratories Lease STANDARD FORM MULTI-TENANT NET LEASE (Non-California)
Lease Agreements
Supernus Pharmaceuticals, Inc.
2010
FIRST AMENDMENT TO LEASE
Lease Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2010
SECOND AMENDMENT TO LEASE
Lease Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2010
THIRD AMENDMENT TO LEASE
Lease Agreements
Supernus Pharmaceuticals, Inc.
2010
INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2010